Risk of Developing Antibodies to Heparin-PF4 After Heart Surgery

CompletedOBSERVATIONAL

Enrollment

1,015

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

March 31, 2009

Study Completion Date

July 31, 2012

Conditions

Thrombosis

Interventions

DRUG

Heparin

Heparin will be used as the intra-operative anticoagulant

Trial Locations (4)

University of North Carolina, Chapel Hill

Duke University Medical Center, Durham

University of Wisconsin, Madison

Mayo Clinic, Rochester, Rochester